cyanidin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Studies (cyanidin) | Trials (cyanidin) | Recent Studies (post-2010) (cyanidin) | Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) |
---|---|---|---|---|---|
388 | 1 | 289 | 3,859 | 8 | 1,052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadigamuwa, CC; Le, VQ; Wimalasena, K | 1 |
1 other study(ies) available for cyanidin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Anthocyanins; Apoptosis; Catalase; Cell Differentiation; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Dopamine; Dose-Response Relationship, Drug; Glutathione Peroxidase; Humans; Membrane Potential, Mitochondrial; Neurons; Neurotoxins; Reactive Oxygen Species; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2015 |